Division of Gastroenterology, Department of Internal Medicine, Yonsei Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Republic of Korea.
Dig Dis Sci. 2012 Jun;57(6):1719-23. doi: 10.1007/s10620-012-2067-x. Epub 2012 Feb 7.
The MiroCam (IntroMedic, Ltd., Seoul, Korea) is a small-bowel capsule endoscope that uses human body communication to transmit data. The potential interactions between cardiac devices and the capsule endoscope are causes for concern, but no data are available for this matter.
This clinical study was designed to evaluate the potential influence of the MiroCam capsules on cardiac devices.
Patients with cardiac pacemakers or implantable cardiac defibrillators referred for evaluation of small bowel disease were prospectively enrolled in this study. Before capsule endoscopy, a cardiologist checked baseline electrocardiograms and functions of the cardiac devices. Cardiac rhythms were continuously monitored by 24-h telemetry during capsule endoscopy in the hospital. After completion of procedures, functions of the cardiac devices were checked again for interference. Images from the capsule endoscopy were reviewed and analyzed for technical problems.
Six patients, three with pacemakers and three with implantable cardiac defibrillators, were included in the study. We identified no disturbances in the cardiac devices and no arrhythmias detected on telemetry monitoring during capsule endoscopy. No significant changes in the programmed parameters of the cardiac devices were noted after capsule endoscopy. There were no imaging disturbances from the cardiac devices on capsule endoscopy.
Capsule endoscopy using human body communication to transmit data was safely performed in patients with cardiac pacemakers or implantable cardiac defibrillators. Images from the capsule endoscopy were not affected by cardiac devices. A further large-scale study is required to confirm the safety of capsule endoscopy with various types of cardiac devices.
MiroCam(韩国首尔 IntroMedic 有限公司)是一种使用人体通信传输数据的小肠胶囊内镜。胶囊内镜与心脏设备之间的潜在相互作用令人担忧,但目前尚无相关数据。
本临床研究旨在评估 MiroCam 胶囊对心脏设备的潜在影响。
前瞻性纳入因小肠疾病就诊并需要评估的、装有心脏起搏器或植入式心脏除颤器的患者。在胶囊内镜检查前,心内科医生检查患者的基础心电图和心脏设备功能。在医院内进行胶囊内镜检查时,通过 24 小时遥测连续监测心脏节律。检查完成后,再次检查心脏设备功能是否受到干扰。评估胶囊内镜图像以确定是否存在技术问题。
本研究共纳入 6 例患者,其中 3 例装有起搏器,3 例装有植入式心脏除颤器。我们未发现心脏设备受到干扰,遥测监测也未发现胶囊内镜检查过程中的心律失常。胶囊内镜检查后,心脏设备的程控参数无明显变化。胶囊内镜检查过程中,心脏设备对图像无影响。需要进一步开展大规模研究,以确认各种类型心脏设备的胶囊内镜检查的安全性。